Earnings History Data for Amylyx Pharmaceuticals, Inc. (AMLX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
08-08-2024 PM AMLX Amylyx Pharmaceuticals, Inc. 133.97 -0.73 -0.38 0.31 Amylyx Pharmaceuticals GAAP EPS of -$1.07
[8/8/2024 8:48 AM]
1.80 -0.08 
(-4.26%)
1.88 0.0 
(0.00%)
1.58 - 22.36 887,421 1,100,000 5,101
09-05-2024 PM AMLX Amylyx Pharmaceuticals, Inc. 133.53 -0.46 0.24 0.02 Amylyx Pharmaceuticals GAAP EPS of -$1.75 misses by $1.76, revenue of $88.64M misses by $9.71M
[5/9/2024 7:16 AM]
1.88 -0.05 
(-2.59%)
1.84 -0.09 
(-4.66%)
1.70 - 30.50 2,858,113 2,080,000 131,637
22-02-2024 PM AMLX Amylyx Pharmaceuticals, Inc. 1,070 0.07 0.20 -0.65 Amylyx Pharmaceuticals GAAP EPS of $0.07 misses by $0.16, revenue of $108.4M beats by $1.36M
[2/22/2024 7:03 AM]
18.46 3.15 
(20.61%)
16.62 1.31 
(8.56%)
11.82 - 38.32 5,100,760 970,000 204,617
09-11-2023 PM AMLX Amylyx Pharmaceuticals, Inc. 1,230 0.30 0.42 -0.92 Amylyx Pharmaceuticals GAAP EPS of $0.30 misses by $0.12, revenue of $102.7M misses by $10.96M
[11/9/2023 7:38 AM]
12.31 -5.69 
(-31.58%)
12.62 -5.38 
(-29.89%)
12.24 - 41.93 9,348,814 1,340,000 543,070
10-08-2023 AH AMLX Amylyx Pharmaceuticals, Inc. 1,460 0.31 0.01 -0.93 Amylyx Pharmaceuticals GAAP EPS of $0.31 beats by $0.35, revenue of $98.2M beats by $6.06M
[8/10/2023 4:30 PM]
21.63 0.46 
(2.17%)
21.20 0.03 
(0.14%)
15.80 - 41.93 1,700,051 1,110,000 5,154
11-05-2023 AH 4:00 PM ET
(May 11)
AMLX Amylyx Pharmaceuticals, Inc. 2,010 0.02 -0.27 -0.93 Amylyx Pharmaceuticals GAAP EPS of $0.02 beats by $0.24, revenue of $0.07M misses by $59.58M
[5/11/2023 4:06 PM]
27.67 -1.15 
(-3.99%)
30.50 1.68 
(5.83%)
6.51 - 41.93 2,850,096 750,000 73,658
13-03-2023 AH 4:00 PM ET
(Mar 13)
AMLX Amylyx Pharmaceuticals, Inc. 2,400 -0.65 -0.77 0.00 Amylyx Pharmaceuticals GAAP EPS of -$0.65 beats by $0.16, revenue of $21.89M beats by $17.17M
[3/13/2023 4:27 PM]
34.21 3.04 
(9.75%)
37.23 6.06 
(19.44%)
6.51 - 41.93 3,768,472 780,000 84,457
10-11-2022 AH 4:00 PM ET
(Nov 10)
AMLX Amylyx Pharmaceuticals, Inc. 2,010 -0.92 -0.97 0.00 Amylyx Pharmaceuticals GAAP EPS of -$0.92 beats by $0.04, revenue of $0.35M beats by $0.27M
[11/10/2022 4:15 PM]
34.10 -1.29 
(-3.63%)
34.25 -1.14 
(-3.22%)
6.51 - 38.76 1,237,848 790,000 6,663
12-05-2022 AH AMLX Amylyx Pharmaceuticals, Inc. 446.00 -0.93 -0.75 0.00 Amylyx Pharmaceuticals GAAP EPS of -$0.93 misses by $0.19
[5/12/2022 5:11 PM]
8.56 1.08 
(14.44%)
7.93 0.45 
(6.02%)
6.51 - 33.41 105,267 270,000 207